Marc Oliva

2.3k total citations · 1 hit paper
41 papers, 1.2k citations indexed

About

Marc Oliva is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Marc Oliva has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Otorhinolaryngology and 11 papers in Surgery. Recurrent topics in Marc Oliva's work include Head and Neck Cancer Studies (16 papers), Cancer Immunotherapy and Biomarkers (13 papers) and CAR-T cell therapy research (8 papers). Marc Oliva is often cited by papers focused on Head and Neck Cancer Studies (16 papers), Cancer Immunotherapy and Biomarkers (13 papers) and CAR-T cell therapy research (8 papers). Marc Oliva collaborates with scholars based in Spain, Canada and United States. Marc Oliva's co-authors include Lillian L. Siu, Tracy Stockley, Eoghan Ruadh Malone, Peter Sabatini, Ricard Mesı́a, Miren Taberna, Anna Spreafico, Bryan Coburn, Laia Alemany and Antonio Rullan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Marc Oliva

38 papers receiving 1.2k citations

Hit Papers

Molecular profiling for precision cancer therapies 2020 2026 2022 2024 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Molecular profiling for precision cancer therapies
    2020 543 citations Marc Oliva, Lillian L. Siu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Oliva Spain 12 519 472 387 271 158 41 1.2k
Emmanuel Blot France 19 639 1.2× 543 1.2× 368 1.0× 207 0.8× 154 1.0× 50 1.4k
John Wrangle United States 18 587 1.1× 841 1.8× 327 0.8× 323 1.2× 240 1.5× 44 1.5k
Collin Tokheim United States 16 343 0.7× 912 1.9× 494 1.3× 162 0.6× 136 0.9× 20 1.3k
Ramona F. Swaby United States 22 1.1k 2.0× 621 1.3× 278 0.7× 289 1.1× 217 1.4× 83 1.8k
Pedro Pérez‐Segura Spain 18 467 0.9× 407 0.9× 294 0.8× 237 0.9× 136 0.9× 117 1.2k
Jean‐Pascal Machiels Belgium 23 808 1.6× 461 1.0× 256 0.7× 290 1.1× 170 1.1× 58 1.6k
Amy E. McCart Reed Australia 22 685 1.3× 707 1.5× 534 1.4× 359 1.3× 78 0.5× 66 1.5k
Shakun Malik United States 18 454 0.9× 316 0.7× 259 0.7× 455 1.7× 83 0.5× 35 993
Lisa Simi Italy 27 706 1.4× 801 1.7× 736 1.9× 403 1.5× 113 0.7× 53 1.8k
Rahul Ladwa Australia 16 986 1.9× 525 1.1× 241 0.6× 365 1.3× 519 3.3× 93 1.7k

Countries citing papers authored by Marc Oliva

Since Specialization
Citations

This map shows the geographic impact of Marc Oliva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Oliva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Oliva more than expected).

Fields of papers citing papers by Marc Oliva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Oliva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Oliva. The network helps show where Marc Oliva may publish in the future.

Co-authorship network of co-authors of Marc Oliva

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Oliva. A scholar is included among the top collaborators of Marc Oliva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Oliva. Marc Oliva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tous, Sara, Beatriz Quirós, Miguel Ángel Pavón, et al.. (2025). Exploring the role of human papillomavirus (HPV) status in body composition and nutritional features in patients with oropharyngeal cancer. Clinical Nutrition ESPEN. 67. 417–426.
2.
Plana, Maria, Sara Tous, Esther Vilajosana, et al.. (2024). Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma. Frontiers in Oncology. 14. 1458479–1458479.
3.
Salvestrini, Viola, Saverio Caini, Pierluigi Bonomo, et al.. (2024). Immunotherapy in elderly head and neck cancer patients: a systematic review and meta-analysis. Frontiers in Oncology. 14. 1395838–1395838. 1 indexed citations
4.
Taylor, Kirsty, Jinfeng Zou, Marc Oliva, et al.. (2023). Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients. European Journal of Cancer. 188. 29–38. 14 indexed citations
5.
Spreafico, Anna, Alya Heirali, Daniel Vilarim Araújo, et al.. (2023). First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial). Annals of Oncology. 34(6). 520–530. 48 indexed citations
6.
Taberna, Miren, Marc Oliva, Robert Montal, et al.. (2021). The potential role of imaging techniques in avoiding neck dissection during salvage surgery after head and neck carcinoma treated with bioradiotherapy. The Journal of Laryngology & Otology. 135(11). 970–975. 1 indexed citations
7.
8.
Arribas, Lorena, Nieves Plana, Miren Taberna, et al.. (2021). Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors. Frontiers in Oncology. 11. 699668–699668. 11 indexed citations
9.
Araújo, Daniel Vilarim, Marc Oliva, Kecheng Li, et al.. (2021). Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era. European Journal of Cancer. 158. 85–98. 16 indexed citations
10.
Oliva, Marc, Rachel Taylor, Jie Su, et al.. (2020). Impact of cumulative cisplatin dose and adjuvant chemotherapy in locally-advanced nasopharyngeal carcinoma treated with definitive chemoradiotherapy. Oral Oncology. 105. 104666–104666. 7 indexed citations
11.
12.
Oliva, Marc, Scott Jennings, Rachel Taylor, et al.. (2020). 977TiP Role of microbiome as a biomarker in locoregionally-advanced oropharyngeal squamous cell carcinoma 2 (ROMA LA-OPSCC2). Annals of Oncology. 31. S685–S686. 1 indexed citations
13.
Antonio, Maite, et al.. (2020). 934P Comparing frailty screening tools for older head and neck cancer patients. Annals of Oncology. 31. S670–S670. 1 indexed citations
14.
Araújo, Daniel Vilarim, Marc Oliva, Alya Heirali, et al.. (2020). Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics. Cancer Treatment Reviews. 92. 102125–102125. 16 indexed citations
15.
Taberna, Miren, Marc Oliva, & Ricard Mesı́a. (2019). Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology. 9. 383–383. 78 indexed citations
16.
Taberna, Miren, M. Mena, Sara Tous, et al.. (2018). HPV-relatedness definitions for classifying HPV-related oropharyngeal cancer patient do impact on TNM classification and patients’ survival. PLoS ONE. 13(4). e0194107–e0194107. 12 indexed citations
17.
Oliva, Marc, Anna Spreafico, Miren Taberna, et al.. (2018). Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma. Annals of Oncology. 30(1). 57–67. 194 indexed citations
18.
Saigí, Maria, Marc Oliva, Luisa Aliste, et al.. (2017). Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre. PLoS ONE. 12(9). e0184737–e0184737. 6 indexed citations
19.
Oliva, Marc, Miren Taberna, Robert Montal, et al.. (2016). Salvage surgery after head and neck squamous cell carcinoma treated with bioradiotherapy. Head & Neck. 39(1). 116–121. 7 indexed citations
20.
Montal, Robert, Marc Oliva, Miren Taberna, et al.. (2016). Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab. Clinical & Translational Oncology. 18(11). 1140–1146. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuel Blot Breakdown of academic impact, for papers by John Wrangle Breakdown of academic impact, for papers by Collin Tokheim Breakdown of academic impact, for papers by Ramona F. Swaby Breakdown of academic impact, for papers by Pedro Pérez‐Segura Breakdown of academic impact, for papers by Jean‐Pascal Machiels Breakdown of academic impact, for papers by Amy E. McCart Reed Breakdown of academic impact, for papers by Shakun Malik Breakdown of academic impact, for papers by Lisa Simi Breakdown of academic impact, for papers by Rahul Ladwa
Rankless by CCL
2026